Fatty Acids from Indonesia and Malaysia; Preliminary Injury Determination

Notice

You may be interested in this older document that published on 02/17/2026 with action 'Notice.' View Document

Fatty Acids From Indonesia and Malaysia; Determinations

A Notice by the International Trade Commission on 04/08/2026

• PDF

• Document Details

• Table of Contents

- Related Documents

• Public Comments
• Regulations.gov Data

- Sharing

• Print
• Other Formats
• Public Inspection Published Document: 2026-06741 (91 FR 17814) Document Headings ###### International Trade Commission

1. [Investigation Nos. 701-TA-785-786 and 731-TA-1773-1774 (Preliminary)] On the basis of the record [1 ] developed in the subject investigations, the United States International Trade Commission (“Commission”) determines, pursuant to the Tariff Act of 1930 (“the Act”), that there is a reasonable indication that an industry in the United States is materially injured by reason of imports of fatty acids from Indonesia and Malaysia, provided for in subheadings 2915.70.01, 2915.90.10, 2916.15.10, 2916.15.51, 3823.11.00, 3823.12.00, 3823.19.20, and 3823.19.40 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than fair value (“LTFV”) and imports of the subject merchandise from Indonesia and Malaysia that are alleged to be subsidized by the governments of Indonesia and Malaysia. [2 ]

Commencement of Final Phase Investigations

Pursuant to section 207.18 of the Commission's rules, the Commission also gives notice of the commencement of the final phase of its investigations. The Commission will issue a final phase notice of scheduling, which will be published in the Federal Register as provided in § 207.21 of the Commission's rules, upon notice from the U.S. Department of Commerce (“Commerce”) of affirmative preliminary determinations in the investigations under §§ 703(b) or 733(b) of the Act, or, if the preliminary determinations are negative, upon notice of affirmative final determinations in those investigations under §§ 705(a) or 735(a) of the Act. Parties that filed entries of appearance in the preliminary phase of the investigations need not enter a separate appearance for the final phase of the investigations. Any other party may file an entry of appearance for the final phase of the investigations after publication of the final phase notice of scheduling. Industrial users, and, if the merchandise under investigation is sold at the retail level, representative consumer organizations have the right to appear as parties in Commission antidumping and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to the investigations. As provided in section 207.20 of the Commission's rules, the Director of the Office of Investigations will circulate draft questionnaires for the final phase of the investigations to parties to the investigations, placing copies on the Commission's Electronic Document Information System (EDIS, https://edis.usitc.gov), for comment.

Background

On January 28, 2026, Vantage Specialty Chemicals, Inc., Deerfield, Illinois, filed petitions with the Commission and Commerce, alleging that an industry in the United States is materially injured or threatened with material injury by reason of subsidized imports of fatty acids from Indonesia and Malaysia and LTFV imports of fatty acids from Indonesia and Malaysia. Accordingly, effective January 28, 2026, the Commission instituted countervailing duty investigation Nos. 701-TA-785-786 and antidumping duty investigation Nos. 731-TA-1773-1774 (Preliminary).

Notice of the institution of the Commission's investigations and of a public conference to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of February 2, 2026 (91 FR 4616). [3 ] The Commission conducted its conference on February 18, 2026. All persons who requested the opportunity were permitted to participate.

The Commission made these determinations pursuant to §§ 703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It completed and filed its determinations in these investigations on April 3, 2026. The views of the Commission are contained in USITC Publication 5723 (April 2026), entitled Fatty Acids from Indonesia and Malaysia: Investigation Nos. 701-TA-785-786 and 731-TA-1773-1774 (Preliminary).

By order of the Commission.

Issued: April 3, 2026.

Lisa Barton,

Secretary to the Commission.

Footnotes

1.

                     The record is defined in § 207.2(f) of the Commission's Rules of Practice and Procedure ([19 CFR 207.2(f)](https://www.ecfr.gov/current/title-19/section-207.2#p-207.2(f))).

Back to Citation 2. 91 FR 12342 and 91 FR 12353 (March 13, 2026).

Back to Citation 3.

                     The Commission published a revised schedule on February 17, 2026 ([91 FR 7301](https://www.federalregister.gov/citation/91-FR-7301)) to conform with Commerce's new schedule after Commerce extended the deadline for its initiation determinations from February 17, 2026 to March 9, 2026 ([91 FR 6192](https://www.federalregister.gov/citation/91-FR-6192), February 11, 2026).

Back to Citation [FR Doc. 2026-06741 Filed 4-7-26; 8:45 am]

BILLING CODE 7020-02-P

Published Document: 2026-06741 (91 FR 17814)